BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supplies for a high-throughput quantitative serology method to identify people who have had COVID-19 and have developed antibodies. This will help provide a better understanding of the disease and inform the next stages of the COVID-19 strategy. The Contract allows the Authority to place orders for the goods specified in the contract up to the maximum value however it is not a committed volume. The Authority agrees to collaborate weekly with the Supplier to agree to a ninety (90) day forecast, specifying quantities of Goods required by week ("Weekly Forecast"). Only the quantities set forth in the Weekly Forecast for the upcoming two (2) weeks shall be binding.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbott Laboratories Ltd | 00329102 | £135,161,955 | LOBBYIST Newmarket Strategy Limited (1 quarter) |
Government spending data: This supplier has received £166,193,822 in 2,343 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Plymouth Hospitals NHS Trust, Royal Cornwall Hospitals NHS Trust, The Royal Wolverhampton NHS Trust and 11 more public bodies (2018-07-05 to 2026-03-31). View full payment history →